14030-1: Iridex EndoProbe Handpiece 20G Stepped Angled 45°

Sign in to add this product to your favorites!
| Price: | $5.65 EACH |
|---|---|
| Quantity: | |
| In Stock: | 1 eaches |
| Status: | expired |
| Express: | Need it tomorrow? Order in next 1 hours 46 minutes and choose overnight shipping at checkout. |
Additional Details
EndoProbe Handpiece
Stepped Angled
- Smooth and gently tapered needle permits insertion of angled tip through standard and valved cannulas
- Patented design provides full coverage of peripheral retina without removing probe from eye
- Offers rigid, fixed 45° angle for a sturdy alternative to flex-tip probes
AccessGUDID Info
- FDA Product Code: GEX
- FDA Product Code Name: Powered Laser Surgical Instrument
- GMDN Term Code: 61162
- GMDN Term Name: Ophthalmic laser system beam guide
- GMDN Term Description: A sterile, hand-held, probe-like device intended to be used in conjunction with an ophthalmic laser system during ophthalmic surgery to invasively direct and deliver laser energy to treat non-refractive conditions (e.g., to repair a retinal tear). It consists of a fibreoptic cable, a handpiece, and a distal invasive cannula/probe which may be available in a variety of configurations (e.g., bent or straight); it may be capable of further functionality (e.g., aspiration, illumination). This is a single-use device.
Manufacturer
Iridex Corporation is a medical device company specializing in laser-based ophthalmic treatments for glaucoma and retinal diseases. Their proprietary MicroPulse laser technology delivers precise, tissue-sparing energy for glaucoma therapies, such as MicroPulse transscleral laser therapy (TLT), and retinal applications, including diabetic macular edema (DME) and age-related macular degeneration (AMD). Iridex also offers conventional continuous-wave laser systems for retinal photocoagulation, as well as an extensive line of laser probes, delivery devices, and accessories. The company’s solutions focus on minimally invasive, repeatable treatments aimed at preserving vision and improving quality of life for patients with chronic eye conditions.
IN-DATE